-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : BMO RAISES TARGET PRICE TO $292 FROM $290

Reuters·11/05/2026 12:08:45

Please log in to view news